Trump’s drug price ultimatum sets pharma firms scrambling

0
5


Key Points

  • A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday.
  • President Trump sent letters to 17 major firms outlining the steps they must take to cut costs.
  • Healthcare stocks tumbled Friday, following broader market losses as investors digested Trump’s amended tariffs.


LEAVE A REPLY

Please enter your comment!
Please enter your name here